Mark Dipaolo
Director, NOVELION THERAPEUTICS INC.
Companies
- OneIM Acquisition Corp.Board member Jan 13, 2026 to now1
- Amarin CorporationBoard member Mar 10, 2023 to now2
- Innoviva, Inc.Board member Feb 14, 2018 to now3
- Sarissa Capital Acquisition Corp.Senior Managing Director Oct 20, 2020 to Oct 20, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Innoviva, Inc. INVA140,492 shares5$2.9M at $20.86May 4, 2026
Amarin Corporation AMRN401 shares6$4.5K at $11.32Apr 18, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- May 4, 2026Granted 9,786 shares of Innoviva, Inc.5
- May 19, 2025Granted 12,077 shares of Innoviva, Inc.7
- Apr 18, 2025Shares withheld for tax 437 shares at $9.11 of Amarin Corporation6
- Apr 18, 2025Exercised options 838 shares of Amarin Corporation6
- Jun 17, 2024Granted 13,923 shares of Innoviva, Inc.8
- May 22, 2023Granted 16,495 shares of Innoviva, Inc.9
- Apr 25, 2022Granted 12,647 shares of Innoviva, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAmarin Corporation, Board member
- 3SEC EDGARInnoviva, Inc., Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed May 21, 2025
- 8SEC EDGARForm 4 filed Jun 20, 2024
- 9SEC EDGARForm 4 filed May 24, 2023
- 10SEC EDGARForm 4 filed Apr 27, 2022